Biodexa Pharmaceuticals plc American Depositary Shs
Symbol: BDRX (NASDAQ)
6.75
▲ (1.50%) 0.100
Company Description:
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
Key Stats
- Today's Open: $6.5
- Today's High: $7
- Today's Low: $6.5
- Today's Volume: 161
- Yesterday Close: $6.65
- Yesterday High: $7.068
- Yesterday Low: $6.5
- Yesterday Volume: 24.74K
- Last Min Volume: 1
- Last Min High: $6.75
- Last Min Low: $6.75
- Last Min VWAP: $6.75
Company Profile
- Name: Biodexa Pharmaceuticals plc American Depositary Shs
- Website: https://www.biodexapharma.com
- Listed Date: 2015-12-07
- Location: ,
- Market Status: Active
- CIK Number: 0001643918
- SIC Code:
- SIC description:
- Market Cap: $4.12M
- Round Lot: 100
- Outstanding Shares: 619.52K
- Asset Type: ADRC
RECENT FILINGS FOR BDRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | EFFECT | View |
| 2025-09-26 | F-3 | View |
| 2025-09-12 | 424B3 | View |
| 2025-09-12 | 424B3 | View |
| 2025-09-12 | 424B3 | View |
| 2025-09-12 | 6-K | View |
| 2025-08-18 | 424B3 | View |
| 2025-08-18 | 424B3 | View |
| 2025-08-18 | 424B3 | View |
| 2025-08-18 | 6-K | View |
| 2025-08-06 | 424B3 | View |
| 2025-08-06 | 424B3 | View |
| 2025-08-06 | 424B3 | View |
| 2025-07-31 | 6-K | View |
| 2025-07-18 | 424B3 | View |
| 2025-07-18 | 424B3 | View |
| 2025-07-18 | 424B3 | View |
| 2025-07-15 | 6-K | View |
| 2025-06-27 | 424B3 | View |
| 2025-06-27 | 424B3 | View |
Latest News on BDRX